FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Caris Life Sciences, Inc. Stock AnalysisComprehensive stock analysis for Caris Life Sciences, Inc. (CAI) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCAI
CAI
Caris Life Sciences, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CAI
Home🔹Stocks🔹Caris Life Sciences, Inc.

Caris Life Sciences, Inc.

CAI•NASDAQ

Caris Life Sciences, Inc.

CAI•NASDAQ
Market cap
$4.41B
Sentiment

Your view on CAI

Mkt Cap
$4.41B
Sentiment
Your view
CAI
Caris Life Sciences, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CAI
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Caris Life Sciences, Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
David Dean Halbert
Headquarters
750 West John Carpenter Freeway, Irving, TX, US
Industry
Biotechnology
Sector
Healthcare
CEO
David Dean Halbert
Headquarters
750 West John Carpenter Freeway, Irving, TX, US
Description

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News